Marion Biotech

The central Asian nation has put on trial 21 people – 20 Uzbeks and one Indian – for the deaths.

Uzbekistan kids' death: Manufacturing licence of Marion Biotech cancelled by UP authority

"The firm's licence was under suspension since January after which a detailed inquiry was initiated. Now the licence of the firm has been cancelled by the Uttar Pradesh Drugs Controlling and Licensing Authority. The firm can no longer manufacture the syrup," a government official said.

Uzbek children deaths: DCGI alerts states against firm that supplied raw material to Marion Biotech

The drugs regulator has urged state licensing authorities to issue directions to all manufacturers not to use propylene glycol supplied by Maya Chemtech India

Uzbek children’s deaths: Drug watchdog initiates process of cancelling Marion Biotech’s licence

Twenty-two out of 36 samples of cough syrups made by the company failed drug contamination tests at a central drug laboratory

Uzbek cough syrup deaths: Process underway to cancel license of Marion Biotech, says official

All production of drugs and other activities at the firm's campus in Sector 67 in Noida have also been stopped completely, Gautam Buddh Nagar drug inspector Vaibhav Babbar said.

Uzbekistan cough syrup deaths: Marion Biotech's licence to be cancelled after contamination confirmed

Twenty two out of 36 samples of drugs manufactured by Marion Biotech were found to be contaminated. The state Drugs Controlling and Licensing Authority has started the process of cancellation of manufacturing license of the firm, an official said.

Moneycontrol Selects: Top stories this evening

Our specially curated package of the most interesting articles to help you stay at the top of your game.

Uzbekistan cough syrup deaths: 3 Marion Biotech employees arrested, directors absconding, says police

The Noida police have arrested Marion Biotech’s head of operation Tuhin Bhattacharya, Atul Rawat, the manufacturing chemist, and Mool Singh, the analytical chemist, under various sections of the Indian Penal Code (IPC).

No evidence of deaths due to our cough syrup, attempt to tarnish India’s image: Marion Biotech

Noida-based firm puts up a strong defence in a letter to central and state drug authorities. Company says it followed British Pharmacopoeia standards while manufacturing two controversial syrups. It also questions the methodology used to find the cause of children’s deaths in Samarkand city of Uzbekistan.

Moneycontrol Selects: Top stories this evening

Our specially curated package of the most interesting articles to help you stay at the top of your game.

Killer Cough Syrup: Marion Biotech used untested ingredients procured from unapproved vendors

The firm had not even tested the ingredient properly for the presence of the contaminants diethylene glycol and ethylene glycol, before using it to manufacture the cough syrups.

WHO awaits probe by Indian drug regulator to chart the fate of Marion Biotech

On December 27, Uzbekistan had said that 18 children may have died after consuming contaminated DOK-1 Max syrup by Marion Biotech. WHO issued a medical product alert for two substandard cough syrups by the Uttar Pradesh-based drug maker on February 12

Uzbekistan cough syrup case: Marion Biotech's production licence suspended; WHO issues medical product alert

The World Health Organisation (WHO) has also issued a medical product alert on Ambronol and Dok-1 Max syrups, both manufactured by Marion Biotech in Noida, Uttar Pradesh.

Fresh inspection of Marion Biotech plant on after WHO flags 2 cough syrups

The inspection was ordered after WHO issued ‘medical product alert’ for cough syrups, including the one that was linked to the death of 18 children in Uzbekistan

Uzbekistan cough syrup row: UP suspends manufacturing license of drug maker Marion Biotech

Marion Biotech had its manufacturing licence suspended after failing to respond to a show-cause notice by the regulatory authority.

Cough syrup test report awaited; Marion Biotech gets breather to respond on GMP violations

The Noida-based firm was given seven days to reply on manufacturing practice violations at its plant, but with a drug sample report awaited, the drug regulator has given additional time to the company to respond to the notice.

What can the inspection of select drugmaking units hope to achieve?

Experts point out that laxity on the part of regulators has resulted in substandard and adulterated drugs hitting markets in India and other countries with weak regulatory oversight.

Uzbekistan Cough Syrup Deaths: Pharmexcil suspends membership of Marion Biotech

The suspension means that the company's exports will become ineligible for incentives under the Market Access Initiative Scheme.

Technical panel formed in the aftermath of Maiden Pharma case likely to probe Marion Biotech case too

 A spate of allegations that contaminated drugs were being exported to countries with weak drug regulatory mechanisms indicates that larger reforms may be needed

Uzbekistan cough syrup row: Marion Biotech asked to completely halt drug production at Noida plant

According to the officials involved in the inspection of plants at Noida, a deviation from Schedule M for Good Manufacturing Practices was observed at Marion's plant and the regulators have asked to stop the total production at this unit.

Cough syrup case: Probe team take 6 more samples after day-long check at Noida office

The inspection at Marion Biotech started at around 12 pm and continued for over 10 hours during which six more samples of the syrup were taken, they said.

Uzbekistan cough syrup case: Govt may order category-wise halt of drug production based on probe findings

Two back-to-back cases of cough syrups from India, the first one involving Maiden Pharmaceuticals, which was blamed for supplying contaminated drugs that killed 70 kids in Gambia, have tainted India’s image as the ‘Pharmacy of the World’

Exclusive | Uzbekistan Cough Syrup Case: Drugs sold by Marion Biotech in India under scanner

Drug authorities have asked the drug maker for an undertaking clarifying whether the Doc-1 Max syrup has been supplied in any part of India

Exclusive | Uzbek Cough Syrup row: Drug regulators inspect Marion Biotech's manufacturing site

Sources said that government officials inspected the manufacturing facility till late night and collected the Doc 1-Max cough syrup from the plant. Hasan Raza, Marion Biotech Pharma Company legal head also mentioned that the product has been halted.